NewsBenzinga암젠, 대규모 실제 연구 결과 발표···레파타 치료가 ASCVD 및 이전 스타틴 사용 환자에서 에제티미브 대비 치명적 또는 비치명적 심근경색 위험 20% 감소 암젠, 대규모 실제 연구 결과 발표···레파타 치료가 ASCVD 및 이전 스타틴 사용 환자에서 에제티미브 대비 치명적 또는 비치명적 심근경색 위험 20% 감소 Benzinga 2026.11.05 14:06 (GMT+0) Open on Benzinga Other news New Address Withdraws 1.344 Billion PUMP From Coinbase, Worth About $3.87 Million Key Overnight and Morning News (November 16–17) Crypto Sectors Trade Mixed as DeFi Rises 1.67% While RWA and GameFi Each Drop Over 2% AI Lab Noeri, Founded by Stanford Professors, Raises $110M With Nvidia Among Investors Baidu Q3 Earnings: Total Revenue 30.8 Billion Yuan, AI Business Revenue Share Above Half for Third Straight Quarter Bitcoin, XRP, Dogecoin Slide, Ethereum Steady as ‘Extreme Fear’ Persists: Analyst Says ‘Selling Hasn’t Stopped Yet’ as Whales Offload BTC
Baidu Q3 Earnings: Total Revenue 30.8 Billion Yuan, AI Business Revenue Share Above Half for Third Straight Quarter
Bitcoin, XRP, Dogecoin Slide, Ethereum Steady as ‘Extreme Fear’ Persists: Analyst Says ‘Selling Hasn’t Stopped Yet’ as Whales Offload BTC